Citations

Citations to this article as recorded by  

• Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening
  Suprabhat Giri, Sukanya Bhrugumalla, Akash Shukla, Sagar Gangadhar, Srujan Reddy, Sumaswi Angadi, Leela Shinde, Aditya Kale
  Arab Journal of Gastroenterology.2025; 26(1): 33.     CrossRef
• Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: A comprehensive review
  Daya Krishna Jha, Rinkalben Kakadiya, Ananya Sharma, Shankar Naidu, Dipankar De, Vishal Sharma
  Autoimmunity Reviews.2025; 24(3): 103758.     CrossRef
• Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future
  Manish Manrai, Atul Abhishek Jha, Saurabh Dawra, Aditya Vikram Pachisia
  Future Pharmacology.2024; 4(1): 279.     CrossRef
• RATE OF INFECTION (TUBERCULOSIS) IN BRAZILIANS IBD PRIVATE PATIENTS: FOLLOW-UP 15 YEARS
  Didia B CURY, Liana C B CURY, Ana C MICHELETTI, Rogério A OLIVEIRA, José J S GONÇALVES
  Arquivos de Gastroenterologia.2024;[Epub]     CrossRef
• (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review
  Thomas Theo Brehm, Maja Reimann, Niklas Köhler, Christoph Lange
  Clinical Microbiology and Infection.2024; 30(8): 989.     CrossRef
• “Mitigating tuberculosis reactivation risk in IBD patients on anti-TNF therapy”
  Peeyush Kumar, Saurabh Kedia, Vineet Ahuja
  Arab Journal of Gastroenterology.2024; 25(4): 455.     CrossRef
• Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review
  Nina Jahnich, Peter D. Arkwright
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
  Kyunghwan Oh, Kee Don Choi, Hyeong Ryul Kim, Tae Sun Shim, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
  Clinical Endoscopy.2023; 56(2): 239.     CrossRef
• CT in the detection of latent tuberculosis: a systematic review
  N. Moore, M. Maher, G. Murphy, M. O'Callaghan Maher, O.J. O'Connor, M.F. McEntee
  Clinical Radiology.2023; 78(8): 568.     CrossRef
• Miliary Tuberculosis in a Patient With Ulcerative Colitis Treated With Tofacitinib
  Shruti Verma, Arshdeep Singh, Chandan Kakkar, Ashish Tripathi, Vandana Midha, Ajit Sood
  ACG Case Reports Journal.2023; 10(6): e01066.     CrossRef
• The Risk of Opportunistic Infections in Patients with Inflammatory Bowel Disease
  Maede Ghanaeipour, Nima Behnaminia, Erfan Khadem, Amirhossein Nafari
  The International Journal of Gastroenterology and Hepatology Diseases.2022;[Epub]     CrossRef
• Association of Tumor Necrosis Factor α Inhibitor Use with Diagnostic Features and Mortality of Tuberculosis in the United States, 2010–2017
  Shereen S Katrak, Rongxia Li, Sue Reynolds, Suzanne M Marks, Jessica R Probst, Terence Chorba, Kevin Winthrop, Kenneth G Castro, Neela D Goswami
  Open Forum Infectious Diseases.2022;[Epub]     CrossRef
• Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti‐TNF therapy in tuberculosis endemic region
  Peeyush Kumar, Sudheer K. Vuyyuru, Bhaskar Kante, Pabitra Sahu, Sandeep Goyal, Deepak Madhu, Saransh Jain, Mukesh Kumar Ranjan, Sandeep Mundhra, Rithvik Golla, Mukesh Singh, Shubi Virmani, Anvita Gupta, Nidhi Yadav, Mani Kalaivani, Raju Sharma, Prasenjit
  Alimentary Pharmacology & Therapeutics.2022; 55(11): 1431.     CrossRef
• Increased Risk of Infection With High Infliximab Trough Level
  Suprabhat Giri, Harish Darak
  Journal of Clinical Gastroenterology.2022; 56(4): 374.     CrossRef
• Editorial: choosing the optimal screening method for latent TB in patients with IBD commencing anti‐TNF‐therapy—authors' reply
  Peeyush Kumar, Sudheer Kumar Vuyyuru, Saurabh Kedia, Vineet Ahuja
  Alimentary Pharmacology & Therapeutics.2022; 55(10): 1348.     CrossRef
• Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective
  Shubhra Mishra, Anuraag Jena, Rinkalben Kakadiya, Vishal Sharma, Vineet Ahuja
  Expert Review of Gastroenterology & Hepatology.2022; 16(8): 737.     CrossRef
• Tumor necrosis factor-alpha antibody labeled-polyethylene glycol-coated nanoparticles: A mesenchymal stem cells-based drug delivery system in the rat model of cisplatin-induced nephrotoxicity
  Faten A. M. Abo-Aziza, Saleh M. Albarrak, Abdel-Kader A. Zaki, Shaymaa E. El-Shafey
  Veterinary World.2022; : 2475.     CrossRef
• Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis
  Peeyush Kumar, Sudheer K. Vuyyuru, Bhaskar Kante, Saurabh Kedia, Pabitra Sahu, Mukesh Kumar Ranjan, Sandeep Mundhra, Rithvik Golla, Mukesh Kumar, Shubi Virmani, Anvita Gupta, Nidhi Yadav, Govind Makharia, Vineet Ahuja
  Indian Journal of Gastroenterology.2022; 41(5): 446.     CrossRef
• Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia
  Shu-Chen Wei, Jose Sollano, Yee Tak Hui, Wei Yu, Paul V. Santos Estrella, Lyndon John Q. Llamado, Nana Koram
  Expert Review of Gastroenterology & Hepatology.2021; 15(3): 275.     CrossRef
• Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents
  Adam Krusiński, Anna Grzywa-Celińska, Katarzyna Szewczyk, Luiza Grzycka-Kowalczyk, Justyna Emeryk-Maksymiuk, Janusz Milanowski, Andrew S. Day
  International Journal of Inflammation.2021; 2021: 1.     CrossRef
• Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
  Sudheer K Vuyyuru, Devendra Desai, Saurabh Kedia, Pavan Dhoble, Pabitra Sahu, Bhaskar Kante, Samagra Agarwal, Sawan Bopanna, Rajan Dhingra, Pratap Mouli Venigalla, Raju Sharma, Siddhartha Datta Gupta, Govind Makharia, Peush Sahni, Vineet Ahuja
  JGH Open.2021; 5(4): 420.     CrossRef
• Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
  Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
  Intestinal Research.2021; 19(3): 291.     CrossRef
• Monitoring frequency of interferon gamma release assay for tuberculosis surveillance following infliximab therapy in patients with Crohn's disease
  Qin Yu Yang, Yi Juan Liu, Ye Xu, Lin Zhang, Cheng Dang Wang
  Journal of Digestive Diseases.2021; 22(8): 473.     CrossRef
• COVID-19-associated opportunistic infections: a snapshot on the current reports
  Amir Abdoli, Shahab Falahi, Azra Kenarkoohi
  Clinical and Experimental Medicine.2021; 22(3): 327.     CrossRef
• Efficacy and Safety of Fecal Transplantation Versus Targeted Therapies in Ulcerative Colitis: Network Meta-Analysis
  Sudheer K Vuyyuru, Saurabh Kedia, Mani Kalaivani, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh K Ranjan, Govind Makharia, Ashwin Ananthakrishnan, Vineet Ahuja
  Future Microbiology.2021; 16(15): 1215.     CrossRef
• A case report of probable ocular tuberculosis following biologics
  Sudha K. Ganesh, Divya Thatikonda
  Indian Journal of Ophthalmology - Case Reports.2021; 1(4): 683.     CrossRef
• Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
  Jae Yong Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Ho-Su Lee, Kyung-Wook Jo, Sang Hyoung Park
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Tacrolimus as rescue therapy for steroid-dependent/steroid-refractory ulcerative colitis: Experience from tertiary referral center in India
  Sukrit Sud, Sanjeev Sachdeva, Amarender Singh Puri
  Indian Journal of Gastroenterology.2021; 40(6): 598.     CrossRef
• Vedolizumab in Inflammatory Bowel Disease: West versus East
  Prasanta Debnath, Pravin M. Rathi
  Inflammatory Intestinal Diseases.2021; 6(1): 1.     CrossRef
• Antitubercular Therapy Given to Differentiate Crohn’s Disease From Intestinal Tuberculosis Predisposes to Stricture Formation
  Akshita Gupta, Venigalla Pratap Mouli, Srikant Mohta, Bhaskar Kante, Mani Kalaivani, Deepak Madhu, Pabitra Sahu, Sudheer Kumar, Raju Sharma, Peush Sahni, Prasenjit Das, Siddharth Datta Gupta, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Journal of Crohn's and Colitis.2020; 14(11): 1611.     CrossRef
• Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India
  Pabitra Sahu, Sudheer K. Vuyyuru, Bhaskar Kante, Ashish Agarwal, Raju Sharma, Prasenjit Das, Rajesh Panwar, Saransh Jain, Sawan Bopanna, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Indian Journal of Gastroenterology.2020; 39(4): 388.     CrossRef
• Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model
  Jung Min Kim, Da Hye Kim, Hyo Jeong Park, Hyun Woo Ma, I Seul Park, Mijeong Son, So Youn Ro, Seokmann Hong, Hyo Kyung Han, Soo Jeong Lim, Seung Won Kim, Jae Hee Cheon
  Journal of Nanobiotechnology.2020;[Epub]     CrossRef
• Long-term outcomes in perianal fistulizing Crohn’s disease in a resource-limited setting: A cohort analysis
  Sudheer K. Vuyyuru, Pabitra Sahu, Saurabh Kedia, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Raju Sharma, Govind Makharia, S. D. Gupta, Peush Sahni, Vineet Ahuja
  Indian Journal of Gastroenterology.2020; 39(5): 435.     CrossRef
• Higher risk of tuberculosis in combination therapy for inflammatory bowel disease
  Seong Ji Choi, Min Sun Kim, Eun Sun Kim, Juneyoung Lee, Jae Min Lee, Hyuk Soon Choi, Bora Keum, Yoon Tae Jeen, Hong Sik Lee, Hoon Jai Chun, Chang Duck Kim
  Medicine.2020; 99(44): e22897.     CrossRef
• Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia
  Rupa Banerjee, Partha Pal, Joyce Wing Yan Mak, Siew C Ng
  The Lancet Gastroenterology & Hepatology.2020; 5(12): 1076.     CrossRef
• Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study
  Nagesh Kamat, Saurabh Kedia, Uday C. Ghoshal, Abhimanyu Nehra, Govind Makharia, Ajit Sood, Vandana Midha, Varun Gupta, Gourdas Choudhuri, Vineet Ahuja
  Indian Journal of Gastroenterology.2019; 38(1): 44.     CrossRef
• Multidrug-resistant Disseminated Tuberculosis Related to Infliximab in a Patient with Ulcerative Colitis and Negative Evaluation for Latent Tuberculosis
  Yu Kyung Jun, Jaeyoung Chun, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim
  The Korean Journal of Gastroenterology.2019; 74(3): 168.     CrossRef

Abdominal computed tomography (CT) can noninvasively image the entire gastrointestinal tract and assess extraintestinal features that are important in differentiating Crohn's disease (CD) and intestinal tuberculosis (ITB). The present meta-analysis pooled the results of all studies on the role of CT abdomen in differentiating between CD and ITB. We searched PubMed and Embase for all publications in English that analyzed the features differentiating between CD and ITB on abdominal CT. The features included comb sign, necrotic lymph nodes, asymmetric bowel wall thickening, skip lesions, fibrofatty proliferation, mural stratification, ileocaecal area, long segment, and left colonic involvements. Sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio (DOR) were calculated for all the features. Symmetric receiver operating characteristic curve was plotted for features present in >3 studies. Heterogeneity and publication bias was assessed and sensitivity analysis was performed by excluding studies that compared features on conventional abdominal CT instead of CT enterography (CTE). We included 6 studies (4 CTE, 1 conventional abdominal CT, and 1 CTE+conventional abdominal CT) involving 417 and 195 patients with CD and ITB, respectively. Necrotic lymph nodes had the highest diagnostic accuracy (sensitivity, 23%; specificity, 100%; DOR, 30.2) for ITB diagnosis, and comb sign (sensitivity, 82%; specificity, 81%; DOR, 21.5) followed by skip lesions (sensitivity, 86%; specificity, 74%; DOR, 16.5) had the highest diagnostic accuracy for CD diagnosis. On sensitivity analysis, the diagnostic accuracy of other features excluding asymmetric bowel wall thickening remained similar. Necrotic lymph nodes and comb sign on abdominal CT had the best diagnostic accuracy in differentiating CD and ITB.

Citations

Citations to this article as recorded by  

• Differentiation of Crohn's disease, ulcerative colitis, and intestinal tuberculosis by dual-layer spectral detector CT enterography
  M. Huang, L. Tu, J. Li, X. Yue, L. Wu, M. Yang, Y. Chen, P. Han, X. Li, L. Zhu
  Clinical Radiology.2024; 79(3): e482.     CrossRef
• Deep Learning Radiomics Analysis of CT Imaging for Differentiating Between Crohn’s Disease and Intestinal Tuberculosis
  Ming Cheng, Hanyue Zhang, Wenpeng Huang, Fei Li, Jianbo Gao
  Journal of Imaging Informatics in Medicine.2024; 37(4): 1516.     CrossRef
• New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis
  Himanshu Narang, Saurabh Kedia, Vineet Ahuja
  Current Opinion in Infectious Diseases.2024; 37(5): 392.     CrossRef
• Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management,
  Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
  Journal of Gastroenterology and Hepatology.2023; 38(4): 510.     CrossRef
• Granulomatous bowel disease: Crohn’s disease and tuberculosis. Difficulties in differential diagnosis (case report and review)
  A. V. Vardanyan, E. S. Merkulova, V. A. Belinskaya, K. S. Frolova, O. A. Mainovskaya
  Koloproktologia.2023; 22(1): 117.     CrossRef
• Evidence-based approach to diagnosis and management of abdominal tuberculosis
  Daya Krishna Jha, Mythili Menon Pathiyil, Vishal Sharma
  Indian Journal of Gastroenterology.2023; 42(1): 17.     CrossRef
• Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review
  Arup Choudhury, Jasdeep Dhillon, Aravind Sekar, Pankaj Gupta, Harjeet Singh, Vishal Sharma
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests
  Preeti Mor, Bhawna Dahiya, Sanjeev Parshad, Pooja Gulati, Promod K. Mehta
  Expert Review of Gastroenterology & Hepatology.2022; 16(1): 33.     CrossRef
• Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
  Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, Deepak Madhu, Pabitra Sahu, Bhaskar Kante, Prasenjit Das, Ankur Goyal, Karan Madan, Govind Makharia, Vineet Ahuja
  Intestinal Research.2022; 20(2): 184.     CrossRef
• Systematic reporting of computed tomography enterography/enteroclysis as an aid to reduce diagnostic dilemma when differentiating between intestinal tuberculosis and Crohn's disease: A prospective study at a tertiary care hospital
  Amrin Israrahmed, Rajanikant R Yadav, Geeta Yadav, Alpana, Rajesh V Helavar, Praveer Rai, Manoj Kumar Jain, Archna Gupta
  JGH Open.2021; 5(2): 180.     CrossRef
• Intestinal Tuberculosis: A Diagnostic Challenge
  Hansang Park, Tikal Kansara, Ana M Victoria, Noella Boma, Jungrak Hong
  Cureus.2021;[Epub]     CrossRef
• Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
  Saurabh Kedia, Vineet Ahuja
  JGH Open.2021; 5(2): 177.     CrossRef
• Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis
  Jung Min Kim, Jun Gu Kang, Sungwon Kim, Jae Hee Cheon
  Journal of Gastroenterology and Hepatology.2021; 36(8): 2141.     CrossRef
• Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
  Ritika Rampal, Saurabh Kedia, Mohamad Nahidul Wari, Deepak Madhu, Amit Kumar Singh, Veena Tiwari, V. Pratap Mouli, Srikant Mohta, Govind Makharia, Vineet Ahuja
  Intestinal Research.2021; 19(2): 232.     CrossRef
• Correlation-driven framework based on graph convolutional network for clinical disease classification
  Kai Cao, Ying Xiao, Muzhou Hou
  Journal of Statistical Computation and Simulation.2021; 91(15): 3108.     CrossRef
• Difficulties in the differential diagnosis of intestinal tuberculosis and Crohn‘s disease
  M. N. Reshetnikov, D. V. Plotkin, Yu. R. Zyuzya, A. A. Volkov, O. N. Zuban, E. M. Bogorodskaya
  Acta Biomedica Scientifica.2021; 6(5): 196.     CrossRef
• Diagnostic performance of CT for differentiating peritoneal tuberculosis from peritoneal carcinomatosis: a systematic review and meta-analysis
  J. Chen, S. Liu, Y. Tang, X. Zhang, M. Cao, Z. Xiao, M. Ren, T. Chen
  Clinical Radiology.2020; 75(5): 396.e7.     CrossRef
• Disseminated tuberculosis presenting as massive lower gastrointestinal bleeding
  Nehal Aggarwal, SubodhKumar Mahto, Akanskha Singh, Kritika Gupta, Ankita Aneja, Anu Singh, Atul Goel
  Journal of Family Medicine and Primary Care.2020; 9(2): 1226.     CrossRef
• Differentiating Crohn’s disease from intestinal tuberculosis
  Saurabh Kedia, Prasenjit Das, Kumble Seetharama Madhusudhan, Siddhartha Dattagupta, Raju Sharma, Peush Sahni, Govind Makharia, Vineet Ahuja
  World Journal of Gastroenterology.2019; 25(4): 418.     CrossRef
• The potential role of CT enterography and gastrointestinal ultrasound in the evaluation of anti-tubercular therapy response of intestinal tuberculosis: a retrospective study
  Li Ma, Qingli Zhu, Yue Li, Wenbo Li, Xuan Wang, Wei Liu, Jianchu Li, Yuxin Jiang
  BMC Gastroenterology.2019;[Epub]     CrossRef
• Indian guidelines on imaging of the small intestine in Crohn’s disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement
  Saurabh Kedia, Raju Sharma, Govind Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C Ghosha, Naveen Kalra, R Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Puri, Sunil Puri, Saroj
  Indian Journal of Radiology and Imaging.2019; 29(02): 111.     CrossRef
• Imaging in discriminating intestinal tuberculosis and Crohn’s disease: past, present and the future
  Pradeep Goyal, Jimil Shah, Sonali Gupta, Pankaj Gupta, Vishal Sharma
  Expert Review of Gastroenterology & Hepatology.2019; 13(10): 995.     CrossRef
• Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis
  Saurabh Kedia, Kumble S Madhusudhan, Raju Sharma, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Saransh Jain, Prasenjit Das, Siddhartha Dattagupta, Govind Makharia, Vineet Ahuja
  Journal of Gastroenterology and Hepatology.2018; 33(6): 1234.     CrossRef
• Computed Tomography Enterography: Quantitative Evaluation on Crohn’s Disease Activity
  Jingyun Cheng, Hui Xie, Hao Yang, Ke Wang, Guobin Xu, Guangyao Wu
  Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
• Gastrointestinal Tuberculosis Presenting as Malnutrition and Distal Colonic Bowel Obstruction
  Raja Chandra Chakinala, Zahava C. Farkas, Benjamin Barbash, Khwaja F. Haq, Shantanu Solanki, Muhammad Ali Khan, Edward Esses, Taliya Farooq, Brad Dworkin
  Case Reports in Gastrointestinal Medicine.2018; 2018: 1.     CrossRef
• Diagnostic point-of-care ultrasound (POCUS) for gastrointestinal pathology: state of the art from basics to advanced
  Fikri M Abu-Zidan, Arif Alper Cevik
  World Journal of Emergency Surgery.2018;[Epub]     CrossRef
• Enfermedad de Crohn vs tuberculosis intestinal: un diagnóstico diferencial desafiante. Revisión de tema
  Gabriel Alonso Mosquera-Klinger, Andrea Ucroz Benavides
  Revista Colombiana de Gastroenterología.2018; 33(4): 423.     CrossRef
• Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association
  Saurabh Kedia, Raju Sharma, Govind K. Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C. Ghoshal, Naveen Kalra, D. Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Singh Puri, Sunil
  Indian Journal of Gastroenterology.2017; 36(6): 487.     CrossRef
• Editor’s Pick: Recent Advances in the Diagnosis and Management of Abdominal Tuberculosis
  Harshal S. Mandavdhare, Harjeet Singh, Vishal Sharma
  EMJ Gastroenterology.2017; : 52.     CrossRef